Risk factors of pain in breast cancer survivors: a systematic review and meta-analysis
Breast cancer remains the number 1 lethal malignancy in women. With rising incidence and decreased mortality, the number of breast cancer survivors has increased. Consequently, sequelae, such as pain, are becoming more important.
The purpose of this study was to identify risk factors for the development of pain in breast cancer survivors.
PubMed and Web of Science were systematically screened for studies encompassing risk factors for the development of pain in breast cancer survivors. Meta-analyses were carried out for risk factors described in more than one article. Moderator analysis was performed in case of high heterogeneity (I 2 > 50%) across studies.
Seventeen studies were found eligible. Meta-analyses were performed for 17 factors. Significant differences for the odds of developing chronic pain were found for BMI (overall OR: 1.34, 95%CI 1.08–1.67, p = 0.008), education (overall OR: 1.23, 95%CI 1.07–1.42, p = 0.005), lymphedema (overall OR: 2.58, 95%CI 1.93–3.46, p < 0.00001), smoking status (overall OR: 0.75, 95%CI 0.62–0.92, p = 0.005), axillary lymph node dissection (overall OR: 1.25, 95%CI 1.04–1.52, p = 0.02), chemotherapy (overall OR: 1.44, 95%CI 1.24–1.68, p < 0.00001), and radiotherapy (overall OR: 1.32, 95%CI 1.17–1.48, p < 0.00001). After performing moderator analyses for age, comorbidities, hormone therapy, and breast surgery, hormone therapy became a significant risk factor as well (overall OR: 1.33, 95%CI 1.15–1.54, p = 0.0001).
BMI > 30, education < 12–13 years, lymphedema, not smoking, axillary lymph node dissection, chemotherapy, hormone therapy, and radiotherapy were significantly associated with higher odds for the development of chronic pain, with lymphedema being the biggest risk factor. Lack of uniformity across the studies in defining pain, follow-up, measurement tools, and cut-off values for the diagnosis of pain was noted, resulting in greater inter-study variability.
KeywordsChronic pain Pain Breast cancer survivor Risk factors
Compliance with ethical standards
Jo Nijs is holder of a Chair funded by the Berekuyl Academy, the Netherlands. Roselien Pas is a PhD student funded by the Berekuyl Acadely Chair.
Conflict of interest
The authors declare that they have no conflict of interest.
- 4.Organization, W.H., World cancer report 2014. 2014, Lyonn, France: International Agency for Research on Cancer.Google Scholar
- 8.Pain, I.A.f.t.S.o. Pain, IASP Taxonomy. 2014 2014–10-06 [cited 2016 2016–03-26]; Available from: http://www.iasp-pain.org/Taxonomy - Pain.
- 9.Merskey, H. and N. Bogduk, Eds. Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms. Second edition ed. 1994, IASP Press: SeattleGoogle Scholar
- 13.NCI, O.o.C.S., About Cancer Survivorship Research: Survivorship Definitions.. 2012, Washington, DCGoogle Scholar
- 14.Elmagarmid, A., et al., Rayyan: a systematic reviews web app for exploring and filtering searches for eligible studies for Cochrane Reviews., in Evidence-Informed Public Health: Opportunities and Challenges. Abstracts of the 22nd Cochrane Colloquium. 2014, John Wiley & sons: Hyderabad, IndiaGoogle Scholar
- 20.Higgins, J.P.T. and S. Green, Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.1 [updated September 2008]. Chapter 9: Analysing data and undertaking meta-analyses., ed. J.J. Deeks, J.P.T. Higgins, and D.G. Altman. 2008: The Cochrane Collaboration.Google Scholar
- 23.Romero A et al (2016) Prevalence of persistent pain after breast cancer treatment by detection mode among participants in population-based screening programs. BMC Cancer 16Google Scholar
- 24.Andersen Juhl A, Christiansen P, Damsgaard TE (2016) Persistent pain after breast cancer treatment: A questionnaire-based study on the prevalence, associated treatment variables, and pain type. J Breast Cancer 19(4):447–454Google Scholar
- 35.Bell RJ et al (2014) Persistent breast pain 5 years after treatment of invasive breast cancer is largely unexplained by factors associated with treatment. Journal of Cancer Survivorship 8(1):1–8Google Scholar
- 41.Piper, M., et al (2016), Axillary Web Syndrome: Current Understanding and New Directions for Treatment. Ann Plast SurgGoogle Scholar
- 51.Levy MH, Chwistek M, Mehta RS (2008) Management of chronic pain in cancer survivors. Cancer J 14(6):401–9Google Scholar
- 54.Beckwee, D., et al. (2017) Prevalence of aromatase inhibitor-induced arthralgia in breast cancer: A systematic review and meta-analysis. Support Care CancerGoogle Scholar